A randomized, double-blind, placebo-controlled phase III study of cisplatin plus a fluoropyrimidine with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophogeal junction (GEJ) adenocarcinoma (RAINFALL, NCT02314117) Meeting Abstract


Authors: Fuchs, C. S.; Tabernero, J.; Al-Batran, S. E.; Chau, I.; Ilson, D. H.; Van Cutsem, E.; Ferry, D.; Emig, M.; Melemed, A. S.; Vanvoorden, V.; Hsu, Y. Z.; Xu, Y. H.; Sashegyi, A.; Das, M.; Shah, M. A.
Abstract Title: A randomized, double-blind, placebo-controlled phase III study of cisplatin plus a fluoropyrimidine with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophogeal junction (GEJ) adenocarcinoma (RAINFALL, NCT02314117)
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904739
PROVIDER: wos
Notes: Meeting Abstract: TPS4131 -- Source: Wos
MSK Authors
  1. David H Ilson
    269 Ilson